Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sacral Neuromodulation for Refractory Overactive Bladder: Closing the Gaps in Anatomy, Mechanisms, and Parameter Selection.

Advances in therapy·2026
Same authorSame journal

Response to Letter to the Editor re: "Factors Associated With Persistent Bothersome Urinary Symptoms and Leakage After Pregnancy".

Urogynecology (Philadelphia, Pa.)·2026
Same author

Sacrospinous Hysteropexy With Mesh vs Vaginal Hysterectomy for Treatment of Uterovaginal Prolapse: 10-Year Results of a Randomized Clinical Trial.

JAMA surgery·2026
Same author

Goal Achievement in Women With Urinary Incontinence After Midurethral Sling.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Technique for Implantable Tibial Nerve Stimulator Placement.

International urogynecology journal·2026
Same author

Gender-Affirming Testosterone Treatment and Lower Urinary Tract Symptoms.

Urogynecology (Philadelphia, Pa.)·2026

Related Experiment Video

Updated: Jul 5, 2025

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
10:19

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

19.3K

Trial Design for Mixed Urinary Incontinence: Midurethral Sling Versus Botulinum Toxin A.

Heidi S Harvie, Holly E Richter1, Vivian W Sung2

  • 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.

Urogynecology (Philadelphia, Pa.)
|January 11, 2024
PubMed
Summary

This study compares onabotulinumtoxinA injections to midurethral slings for treating mixed urinary incontinence (MUI) in women. Results will guide treatment decisions for those unresponsive to oral medications.

More Related Videos

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.1K
Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

967

Related Experiment Videos

Last Updated: Jul 5, 2025

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
10:19

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

19.3K
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.1K
Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

967

Area of Science:

  • Urology
  • Gynecology
  • Pelvic Floor Disorders

Background:

  • Mixed urinary incontinence (MUI) is a prevalent condition that presents significant management challenges.
  • Many women with MUI do not respond adequately to oral treatments, necessitating procedural interventions.

Purpose of the Study:

  • To compare the efficacy of intradetrusor onabotulinumtoxinA injections versus midurethral sling (MUS) placement for treating women with MUI refractory to oral therapy.
  • To evaluate these procedures as treatment options for women seeking relief from MUI symptoms.

Main Methods:

  • The Midurethral sling versus Botulinum toxin A (MUSA) trial is a multicenter, randomized study involving 150 women with MUI.
  • Participants were randomized to receive either 100 U of onabotulinumtoxinA or an MUS procedure.
  • The primary outcome measure is the change in the Urogenital Distress Inventory (UDI) score at 6 months.

Main Results:

  • Recruitment and randomization of 150 participants are complete.
  • Participants are currently in the follow-up phase of the trial.

Conclusions:

  • The MUSA trial is expected to provide crucial data to inform clinical practice for women with refractory MUI.
  • Findings will guide the selection of onabotulinumtoxinA or MUS for women seeking procedural treatment for MUI.